CD163 and hemorrhagic stroke: With secondary toxic hemolytic products, pro-inflammatory molecules, and oxidative damage resulting from ICH in both the short and long term, research has begun to point toward sCD163 to indicate hemorrhagic stroke severity as well as a point of modulation.